Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.24M Buy
8,993
+617
+7% +$211K 0.35% 62
2026
Q1
$2.93M Buy
8,376
+727
+10% +$259K 0.39% 59
2025
Q4
$2.51M Sell
7,649
-1,607
-17% -$510K 0.34% 65
2025
Q3
$2.57M Sell
9,256
-306
-3% -$88.7K 0.31% 68
2025
Q2
$2.52M Buy
+9,562
New +$2.71M 0.33% 67
2025
Q1
Sell
-8,116
Closed -$2.23M 98
2024
Q4
$2.23M Sell
8,116
-443
-5% -$131K 0.35% 63
2024
Q3
$2.76M Sell
8,559
-264
-3% -$86.4K 0.46% 52
2024
Q2
$2.77M Buy
8,823
+563
+7% +$165K 0.51% 49
2024
Q1
$2.35M Buy
8,260
+277
+3% +$81.1K 0.55% 47
2023
Q4
$2.42M Buy
+7,983
New +$2.18M 0.52% 50
2023
Q3
Sell
-3,147
Closed -$696K 163
2023
Q2
$696K Sell
3,147
-2,082
-40% -$483K 0.17% 105
2023
Q1
$1.26M Buy
5,229
+1,558
+42% +$382K 0.33% 64
2022
Q4
$971K Buy
3,671
+1,556
+74% +$417K 0.26% 74
2022
Q3
$483K Buy
2,115
+1
+0% +$242 0.16% 137
2022
Q2
$519K Buy
2,114
+52
+3% +$12.7K 0.15% 125
2022
Q1
$519K Buy
+2,062
New +$474K 0.12% 123

Other funds holding AMGN

Symphony Financial's AMGN Position: Q2 2026 in Review

Symphony Financial increased its Amgen (AMGN) stake by 7.4% in Q2 2026, buying an estimated $211K and bringing the position to 8,993 shares worth $3.24M. The position accounts for 0.35% of the portfolio, ranked #62.

Symphony Financial first reported a position in AMGN in Q1 2022 and has held it in 16 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Symphony Financial held 8,993 shares of Amgen worth $3.24M as of Q2 2026.
  • Symphony Financial bought 617 Amgen shares in Q2 2026, an estimated $211K.
  • Amgen made up 0.35% of Symphony Financial's portfolio in Q2 2026, its #62 holding.
  • Symphony Financial first reported a position in Amgen in Q1 2022 and has held it in 16 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Symphony Financial's 13F filing for Q2 2026, filed 4 Aug 2026.